The two most important factors in the development of rhegmatogenous retinal detachment are retinal breaks and vitreous traction. The two goals of retinal reattachment surgery are to seal all ...
The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.
Pykus Therapeutics, Inc. ("Pykus" or the "Company"), a clinical-stage medical technology company, announced today that it will present an overview of its investigational retinal sealant, PYK-2101, at ...
Age-related macular degeneration (AMD) AMD is a common eye condition that happens as you get older. It affects the macula, ...
High levels of exposure to air pollution can increase the incidence of diabetic retinopathy and glaucoma, a recent study ...
The following is a summary of “Cystoid Macular Edema Following Rhegmatogenous Retinal Detachment Repair Surgery: Incidence, Pathogenesis, Risk Factors and Treatment,” published in the February 2025 ...
Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") announced their abstract of a preclinical study of KIO ...
NY Retina, a newly launched ophthalmology practice, is set to open March 20 in a newly purchased medical office building in ...
New anti–vascular endothelial growth factor (VEGF) therapies are improving retinal disease management by providing patients ...
The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for SYD-101 (atropine sulfate) to slow the progression of ...
Atsena Therapeutics, a clinical-stage gene therapy company focused on using the life-changing power of genetic medicine to reverse or prevent blindness, today announced that the U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback